Engineered Influenza Neuraminidase Antigens
Singapore
11202252530H
Filed on 2021-03-04
11202252530H
Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens
South Korea
10-2022-7034599
Filed on 2021-03-04
10-2022-7034599
Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens
China
202180019311.0
Filed on 2021-03-04
202180019311.0
Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens
Australia
2021231832
Filed on 2021-03-04
2021231832
Filed on 2021-03-04
Engineered Influenza Neuraminidase Antigens
Canada
3170375
Filed on 2022-09-01
3170375
Filed on 2022-09-01
Engineered Influenza Neuraminidase Antigens
Japan
2022-554464
Filed on 2021-03-04
2022-554464
Filed on 2021-03-04
Development Of Dengue Virus Vaccine Components
US Application 18/355,265
Filed on 2023-07-19
Filed on 2023-07-19
METHOD OF IMMMUNOFOCUSING AN IMMUNE RESPONSE
Patent Cooperation Treaty
PCT/US2023/070926
Filed on 2023-07-25
PCT/US2023/070926
Filed on 2023-07-25
Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response
Israel
302880
Filed on 2018-04-04
302880
Filed on 2018-04-04